These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35398930)

  • 1. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Nyuykonge B; Lim W; van Amelsvoort L; Bonifaz A; Fahal A; Badali H; Abastabar M; Verbon A; van de Sande W
    Mycoses; 2022 Jun; 65(6):650-655. PubMed ID: 35398930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.
    Lim W; Nyuykonge B; Eadie K; Konings M; Smeets J; Fahal A; Bonifaz A; Todd M; Perry B; Samby K; Burrows J; Verbon A; van de Sande W
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010159. PubMed ID: 35120131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Madurella mycetomatis is highly susceptible to ravuconazole.
    Ahmed SA; Kloezen W; Duncanson F; Zijlstra EE; de Hoog GS; Fahal AH; van de Sande WW
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2942. PubMed ID: 24945848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
    Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
    Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W
    J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
    Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against
    Ma J; Eadie K; Schippers M; Fahal A; Laleu B; Verbon A; van de Sande WWJ
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigrograna mackinnonii, Not Trematosphaeria grisea (syn., Madurella grisea), Is the Main Agent of Black Grain Eumycetoma in Latin America.
    Ahmed SA; González GM; Tirado-Sánchez A; Moreno-López LM; de Hoog S; Bonifaz A
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification of black grain eumycetoma causative agents using rolling circle amplification.
    Ahmed SA; van den Ende BH; Fahal AH; van de Sande WW; de Hoog GS
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3368. PubMed ID: 25474355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
    Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated list of eumycetoma causative agents and their differences in grain formation and treatment response.
    van de Sande WWJ; Fahal AH
    Clin Microbiol Rev; 2024 Jun; 37(2):e0003423. PubMed ID: 38690871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates.
    Baghi N; Shokohi T; Badali H; Makimura K; Rezaei-Matehkolaei A; Abdollahi M; Didehdar M; Haghani I; Abastabar M
    Med Mycol; 2016 Oct; 54(7):757-63. PubMed ID: 27118804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naphthylisoquinoline alkaloids: novel agents against the causative pathogens of eumycetoma and actinomycetoma-
    Khalid SA; Abd Algaffar S; Tajuddeen N; Lombe BK; Bringmann G
    Antimicrob Agents Chemother; 2024 May; 68(5):e0161223. PubMed ID: 38602413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals.
    Ahmed SA; de Hoog GS; Stevens DA; Fahal AH; van de Sande WW
    Med Mycol; 2015 Apr; 53(3):295-301. PubMed ID: 25631481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
    van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
    Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
    Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
    Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin production in coelomycetous agents of black grain eumycetoma.
    Lim W; Parel F; de Hoog S; Verbon A; van de Sande WWJ
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):324-327. PubMed ID: 33463687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New species of Madurella, causative agents of black-grain mycetoma.
    de Hoog GS; van Diepeningen AD; Mahgoub el-S; van de Sande WW
    J Clin Microbiol; 2012 Mar; 50(3):988-94. PubMed ID: 22205798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.
    Konings M; Eadie K; Lim W; Fahal AH; Mouton J; Tesse N; van de Sande WWJ
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009488. PubMed ID: 34106933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.